A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
Clinical trial NCT04903509 · COMPLETED
Trial details
- NCT number
- NCT04903509
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2022-08-26
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.